We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.

MITOVERVE Liposomal NMN Supplement with Resveratrol
Checked against public sources on August 8, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
Testing claimed — documentation not found. The observed listing and a related brand product page both claim third-party testing. Neither names the laboratory or links a product- or lot-specific report. …
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
The checks, one by one
1 promise needs a closer look.
△Claimed without support found1
?Couldn’t verify independently1
No named laboratory or lot-specific certificate was found for this exact product. A related brand page repeats a testing claim but names no issuer; its UPC is not published. NSF, IFOS, USP, and Informed-Sport were not checked in this record. This is a public-evidence limit, not a finding that testing did not occur.
We looked and found no public proof. That does not count against the product.
Marketing language, not scored
NMN + advanced longevity support in one formula
What is worth knowing.
Headlines first. Open evidence only when you want the source trail.
What remains open 4
- No FDA recall matched this brand in the current search.
- We have not found a public label filing for this exact product.
- Barcode checksum is valid; no independent product record was found.
- No dated review-history series is on file yet.
These are evidence gaps, not strikes against the product.
Filed address
30 N. Gould St., #23545, Sheridan, Wyoming 82801, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
Dose and research context
We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.
Price check for this exact product
Amazon
Exact UPC/GTIN match$0.99 per labeled serving
matching UPC/GTIN · checked Aug 8, 2026
View on Amazon ↗Brand website
Official product-page candidate · UPC absentOfficial shopping lead; excluded from exact price comparisons.
Liposomal NMN Supplement with Resveratrol, Spermidine & Fisetin - 4-in-1 NAD+ Booster for Cellular Energy, Anti Aging & Longevity - NAD+ Support for Men & Women, 60 Capsules, 30 Day Supply · Default Title. Confirm the package UPC/GTIN before buying.
Check brand website ↗iHerb
Not confirmedWe only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search iHerb ↗Target
Not confirmedWe only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗Walmart
Not confirmedWe only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Only one exact price was available at build time; prices change by date, seller, and promotion.
The brand-page price is shown as a shopping lead only. It is excluded from the exact-product price difference because the page does not publish this record's matching UPC/GTIN.
The observed listing and related brand page repeat 60 capsules, 30 day supply, 500 mg, 100 mg. That confirms cross-page consistency of the published claim, not the product contents.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
Want to inspect the evidence?
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built August 08, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.